Dr. Martens (LON:DOCS) Trading Up 0.7% - What's Next?

Dr. Martens plc (LON:DOCS - Get Free Report) shares shot up 0.7% on Thursday . The stock traded as high as GBX 60 ($0.81) and last traded at GBX 59.95 ($0.81). 1,098,886 shares were traded during mid-day trading, a decline of 50% from the average session volume of 2,196,119 shares. The stock had previously closed at GBX 59.55 ($0.81).

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada dropped their price objective on shares of Dr. Martens from GBX 7,000 ($94.75) to GBX 6,000 ($81.21) and set a "sector perform" rating on the stock in a research report on Monday, May 19th.

Dr. Martens Price Performance

The company has a market capitalization of £795.54 million, a P/E ratio of 11.62, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The company's 50-day moving average price is GBX 55.34 and its two-hundred day moving average price is GBX 62.91. The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13.

Dr. Martens (LON:DOCS - Get Free Report) last issued its quarterly earnings data on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. As a group, sell-side analysts expect that Dr. Martens plc will post 2.5809394 EPS for the current year.

Dr. Martens Cuts Dividend

The firm also recently declared a dividend, which was paid on Tuesday, April 8th. Investors of record on Thursday, March 6th were paid a GBX 0.85 ($0.01) dividend. The ex-dividend date was Thursday, March 6th. This represents a dividend yield of 1.47%. Dr. Martens's dividend payout ratio (DPR) is presently 42.53%.

Insider Activity at Dr. Martens

In other Dr. Martens news, insider Giles Wilson purchased 32,640 shares of the firm's stock in a transaction that occurred on Tuesday, March 25th. The shares were acquired at an average cost of GBX 54 ($0.73) per share, for a total transaction of £17,625.60 ($23,857.07). Over the last three months, insiders have acquired 33,206 shares of company stock worth $1,792,771. Corporate insiders own 4.36% of the company's stock.

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.